Aveanna Healthcare 2025 Q3 Earnings Record Net Income Surge of 132.8% as Company Turns Profitable

Aveanna Healthcare (NASDAQ: AVAH) delivered a strong earnings performance in Q3 2025, surpassing expectations with a significant net income turnaround and revenue growth. The company raised its full-year guidance, reflecting improved operational execution and strategic initiatives.

Revenue

Driven by robust demand in its core segments, Aveanna reported Q3 2025 revenue of $621.94 million, . , , while the Home Health & , . . The PDS and HHH segments collectively accounted for 99% of total revenue growth, underscoring the company’s focus on high-margin homecare services.

Earnings/Net Income

, a dramatic 132.8% improvement from a $42.84 million loss in 2024 Q3. , . , highlighting operational efficiency and margin expansion. The earnings turnaround, , underscores its effective cost management and strategic initiatives.

Post-Earnings Price Action Review

, . This suggests a modest but effective strategy, particularly considering the stock’s short-term volatility. , , reflecting mixed investor sentiment.

CEO Commentary

. He highlighted strategic priorities: scaling value-based care, enhancing payor partnerships, and optimizing overhead. .

Guidance

. The company anticipates sustained margin leverage and free cash flow generation, . Risks include reimbursement volatility and regulatory shifts, but management remains optimistic about long-term growth.

Additional News

Aveanna completed the acquisition of ThriveSkill Pediatrics, enhancing its pediatric care capabilities. The company also expanded preferred payer agreements, adding five new partnerships in Q3. CEO Jeff Shaner reiterated confidence in the national homecare platform’s scalability and data-driven outcomes.